These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12463302)

  • 1. Pharmaceutical starter samples.
    Teichman PG; Caffee AE
    J Am Board Fam Pract; 2002; 15(6):509-10. PubMed ID: 12463302
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug sample availability and prescribing behavior.
    Watts SA; Replogle WH; Noble SL; Beebe DK
    J Am Board Fam Pract; 2002; 15(6):509. PubMed ID: 12463301
    [No Abstract]   [Full Text] [Related]  

  • 3. The rising utilization and costs of prescription drugs.
    PHC4 FYI; 2004; (26):1-2. PubMed ID: 15344277
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs still influence health costs, but trend abating.
    Capitation Rates Data; 2003 Oct; 8(10):114-20. PubMed ID: 14621548
    [No Abstract]   [Full Text] [Related]  

  • 5. The cost and availability of prescription drugs--what can we do in Massachusetts?
    Carpenter NW; Kedikoglou S
    Issue Brief (Mass Health Policy Forum); 1999 May; (4):1-41. PubMed ID: 12769091
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceutical Research and Manufacturers of America v. Walsh: the Supreme Court allows the states to proceed with expanding access to drugs.
    Jost TS
    Yale J Health Policy Law Ethics; 2004; 4(1):69-84. PubMed ID: 15052860
    [No Abstract]   [Full Text] [Related]  

  • 7. Is importation of drugs from Canada the answer?
    Orr K; Marcoux R
    R I Med J (2013); 2018 Oct; 101(8):12-14. PubMed ID: 30278594
    [No Abstract]   [Full Text] [Related]  

  • 8. Seizures of Canadian drugs rise as Congress, Customs spar.
    Carreyrou J
    Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16909501
    [No Abstract]   [Full Text] [Related]  

  • 9. Drugmakers exit the comfort zone.
    Singer ID
    State Health Care Am; 2001; ():24-6. PubMed ID: 11521318
    [No Abstract]   [Full Text] [Related]  

  • 10. Marketplace. Managed care plans try to cope as drug ads spur patient demand.
    Moskowitz DB
    Med Health; 1998 May; 52(20):suppl 1-2. PubMed ID: 10179010
    [No Abstract]   [Full Text] [Related]  

  • 11. Using drug samples can hinder quality.
    Healthcare Benchmarks Qual Improv; 2004 Mar; 11(3):34-5. PubMed ID: 15002360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Think twice before assuming risk for pharmacy costs.
    Smith DA
    Fam Pract Manag; 1999 Jun; 6(6):17-21. PubMed ID: 10558374
    [No Abstract]   [Full Text] [Related]  

  • 13. Fake pharmaceuticals: how they and relevant legislation or lack thereof contribute to consistently high and increasing drug prices.
    Moken MC
    Am J Law Med; 2003; 29(4):525-42. PubMed ID: 15119247
    [No Abstract]   [Full Text] [Related]  

  • 14. Recycling unused drugs.
    State Legis; 2005; 31(7):11. PubMed ID: 16296565
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinton team works with drug companies to expand access, restrict costs.
    Am J Hosp Pharm; 1993 Mar; 50(3):388, 391. PubMed ID: 8442442
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effective prescribing.
    Sherman DS
    Contemp Longterm Care; 1993 Jan; 16(1):64, 66. PubMed ID: 10123530
    [No Abstract]   [Full Text] [Related]  

  • 17. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
    Poser S
    Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225
    [No Abstract]   [Full Text] [Related]  

  • 18. Managing Medicaid drug expenditures.
    Sudovar SG; Rein SD
    J Health Hum Resour Adm; 1978 Nov; 1(2):200-30. PubMed ID: 10308767
    [No Abstract]   [Full Text] [Related]  

  • 19. Rx cost control: what's your role?
    Guglielmo WJ
    Med Econ; 2003 Feb; 80(4):27-8, 31-2. PubMed ID: 12666646
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmaceutical promotion and GP prescription behaviour.
    Windmeijer F; de Laat E; Douven R; Mot E
    Health Econ; 2006 Jan; 15(1):5-18. PubMed ID: 15945041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.